UNCY
Unicycive Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:
Float & O/S:
Inst Own:
DilutionScan read 42 of Unicycive Therapeutics, Inc.'s SEC filings and found 5 warrant series, 2 convertibles, 1 ATM program, 3 shelf registrations and 1 completed offering on file for UNCY. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.